Small molecule drugs are our first and often last line of defense for many diseases, yet despite decades of research we still do not fully understand why a given drug works in one patient and fails in the next. These unpredictable variations are driven in part by human gut bacteria that can metabolize hundreds of drugs, altering both efficacy and side effect profiles.
To accelerate the identification of the microbial enzymes responsible for drug biotransformations, we developed SIMMER (Similarity algorithms that Identify MicrobioMe Enzymatic Reactions). This computational tool predicts gut microbial enzymes that may perform a query biotransformation (Fig. 1). SIMMER’s predictions can be used to design experiments testing candidate microbial enzymes for the proposed activity.
SIMMER is available for direct use on the web at https://simmer.pollard.gladstone.org/. To query more than ten input reactions at a time, or to consider more than one closest MetaCyc reaction, refer to the command-line tool documentation.
Bustion AE, Nayak RR, Agrawal A, Turnbaugh PJ, Pollard KS. 2023. SIMMER employs similarity algorithms to accurately identify human gut microbiome species and enzymes capable of known chemical transformations. Elife 12. doi:10.7554/eLife.82401.
SIMMER’s source code and latest updates are available on GitHub, enabling users to explore, modify, and contribute to the tool’s development. https://github.com/aebustion/SIMMER.
Annamarie E Bustion, Ayushi Agrawal, Andrew Davis, Alexander R. Pico, Katherine S. Pollard
For assistance, raise an issue on GitHub or contact aebustion [at] gmail [dot] com. Please note that SIMMER is actively updated, and user feedback is appreciated!